Increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome

Diabetes Research and Clinical Practice

Volumn 69, Issue 3, 2005, Pages 249-255

  Mardi, T ^a,b   Toker, S ^a,b   Melamed, S ^a,b,c   Shirom, A ^a,b   Zeltser, D ^a,b   Shapira, I ^a,b   Berliner, S ^a,b   Rogowski, O ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Occupational Health and Rehabilitation Institute Israel   (Israel)

Author keywords

Erythropoiesis; Inflammation; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROPOIESIS; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; BODY MASS INDEX; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 23744466208     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.01.005     Document Type: Article

References (22)

1. M. Barbieri, E. Ragno, and E. Benvenuti New aspects of the insulin resistance syndrome: impact on haematological parameters Diabetologia 44 2001 1232 1237
2. K.M. Choi, J. Lee, and Y.H. Kim Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study Diab. Res. Clin. Pract. 60 2003 205 212
3. P.M. Ridker, J.E. Buring, N.R. Cook, and N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women Circulation 107 2003 391 397
4. S. Cohen, T. Tolshinsky, and O. Rogowski Real time, control adjusted evaluation of intensity of the inflammatory response J. Inform. Techn. Healthcare 1 2003 195 207
5. O. Rogowski, I. Shapira, and A. Zimran Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model Blood Cells Mol. Dis. 34 2005 26 29
6. O. Rogowski, S. Toker, and I. Shapira Values of high sensitivity C-reactive protein in each month of the year in apparently healthy individuals Am. J. Cardiol. 95 2005 152 155
7. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
8. International committee for standardization in hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood, Immunochemistry 2 (1965) 235-254.
9. A. Clauss Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens Acta Haematol. Basel 17 1957 237 246
10. N. Rifai, R.P. Tracy, and P.M. Ridker Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin. Chem. 45 1999 2136 2141
11. S. Miyagawa, M. Kobayashi, N. Konishi, T. Sato, and K. Ueda Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors Br. J. Haematol. 109 2000 555 562
12. J. Ratajczak, Q. Zhang, E. Pertusini, B.S. Wojczyk, M.A. Wasik, and M.Z. Ratajczak The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions - comparison to other cytokines and growth factors Leukemia 12 1998 371 381
13. K. Sawada, S.B. Krantz, E.N. Dessypris, S.T. Koury, and S.T. Sawyer Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development J. Clin. Invest. 83 1989 1701 1709
14. N. Dainiak, and S. Kreczko Interactions of insulin, insulinlike growth factor II, and platelet-derived growth factor in erythropoietic culture J. Clin. Invest. 76 1985 1237 1242
15. N. Bersch, J.E. Groopman, and D.W. Golde Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro J. Clin. Endocrinol. Metab. 55 1982 1209 1211
16. B.S. Stonestreet, M. Goldstein, W. Oh, and J.A. Widness Effects of prolonged hyperinsulinemia on erythropoiesis in fetal sheep Am. J. Physiol. 257 1989 R1199 R1204
17. M. Petakov, L. Biljanovic-Paunovic, G. Jovcic, N. Stojanovic, V. Todorovic, and W. Jelkmann The influence of acute sterile inflammation on erythropoiesis in rats Exp. Hematol. 26 1998 222 227
18. J.A. Widness, J.B. Susa, and J.F. Garcia Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses J. Clin. Invest. 67 1981 637 642
19. G. Weiss Pathogenesis and treatment of anaemia of chronic disease Blood Rev. 16 2002 87 96
20. M.J. Sarnak, H. Tighiouart, and G. Manjunath Anemia as a risk factor for cardiovascular disease in the Atherosclerotic Risk Communities (ARIC) study J. Am. Coll. Cardiol. 40 2002 27 33
21. J.M. Fernandez-Real, and W. Ricart Insulin resistance and chronic cardiovascular inflammatory syndrome Endocr. Rev. 24 2003 278 301
22. T. Klausen, N.V. Olsen, T.D. Poulsen, J.P. Richalet, and B.K. Pedersen Hypoxemia increases serum interleukin-6 in humans Eur. J. Appl. Physiol. Occup. Physiol. 76 1997 480 482